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Fig. S1 Lentiviral vector constructs for engineering RBCs. a, Schematic of pHAGE-based 
and pCCL-FB-based lentiviral vector constructs used for the delivery of CD4, CD4-GpA, and 
CCR5 transgenes. b, Comparison of ubiquitous CMV, EF1-α, UBC, and CASI promoters for 
the expression of CCR5 in erythroid progenitor cells on day 13 of differentiation. 
  





Fig. S2 Comparison of HIV-1 receptor expression levels on CD4-CCR5-RBCs and 
CD4+ T-cells. Flow cytometry analysis of CD4 and CCR5 expression on enucleated CD4-
CCR5-RBCs and Rev-A3R5 CD4+ T-cells. 
  





Fig. S3 BlaM assay reproducibly shows that HIV-1 enters RBC viral traps. a, Flow 
cytometry analysis of HIV-1 infection of engineered RBCs after overnight incubation with a 
CCR5-tropic HIV-1YU2 pseudovirus carrying a Vpr-BlaM fusion protein. These results 
represent an independent biological replicate of the experiment shown in Fig. 2b using 
engineered RBCs from a different in vitro differentiation culture. b, Comparison of CCR5 















Fig. S4 Engineered RBCs express CD4 and CXCR4 and can be infected by X4-tropic 
HIV-1. a, Flow cytometry measurement of CD4 and CXCR4 expression at the end of 
differentiation for control RBCs, CD4-CXCR4-RBCs, and CD4-GpA-CXCR4-RBCs. b, Flow 
cytometry analysis of HIV-1 infection of RBCs expressing a chimeric D1D4-GpA fusion 
protein that contained the CD4 D1D4 domains to evaluate if addition of the CD4 D3D4 
domains enhanced infection. BlaM assays were performed with R5-tropic HIV-1YU2 and 
X4-tropic HIV-1HxBc2 pseudovirus on D1D4-GpA-CCR5-RBCs (left) and D1D4-GpA-
CXCR4-RBCs (right), respectively. 
  





Fig. S5 Comparison of expression levels between CD4-RBCs and CD4-GpA-RBCs. 
Flow cytometry analysis of CD4 and CD4-GpA expression levels on CD4-RBCs and CD4-
GpA-RBCs, respectively, at the end of differentiation. 
  




Fig. S6 In vitro differentiation of BEL-A / CD4-GpA cells consistently produces RBC 
viral traps. a, Flow cytometry analysis of enucleated CD4-GpA-RBCs on day 8 of in vitro 
differentiation. Enucleated RBCs expressed CD235 and did not stain for the nuclear dye 
Hoechst. b, Flow cytometry analysis of CD4-GpA expression on CD235+/Hoechst- BEL-A / 
CD4-GpA cells. These results represent an independent biological replicate of the experiment 
shown in Fig. 5. 
 
